In the case of the rodent DMBA model, the mammary tumors developed reflect the most common less-aggressive human breast cancer, being hormone-sensitive, low proliferative, and with no overexpression of HER2 [23,48]. This evidence concerns the gene ERBB2 and breast carcinoma.